CHICAGO — Taking periodic breaks from a commonly used treatment for prostate cancer could shorten men’s lives, researchers reported here on SaturdayIn a large study, intermittent hormonal therapy proved to be less effective than continuous therapy for certain men with metastatic prostate cancer.The

Doctors often order tests and recommend drugs or procedures when they shouldn’t — sometimes even when they know they shouldn’t. The problem has become so serious that such groups as the American College of Physicians, the ABIM Foundation, the National Physicians Alliance and a coalition of medical s

Concern over drug-resistant strains of TB is growing, with similar ‘incurable’ TB emerging in Italy and Iran. Doctors in Mumbai said 12 patients had a “totally drug resistant” form of the infection, and three have died.The Indian Health Ministry is investigating the cases and has sent a team of doct

Researcher: ภญ.ศิตาพร ยังคง The International Regulation of New Medical Technology: Health Technology Adoption in the European Union, North America, East Asia and in the Developing World

นักวิจัย: Yot Teerawattananon, MD, PhD Dr. Yot Teerawattananon has received the ISPOR Best Contributed Podium Presentation Award on “Value of Information: An application in health economic evaluation of renal replacement therapy in Thailand” at ISPOR 2nd Asia-Pacific Conference, which was held in Sh

Researcher: Yot Teerawattananon, MD, PhD The ISPOR International Fellowship Award was established in 2006 to recognize key individuals who would contribute to the development of pharmacoeconomics and outcomes research or the use of outcomes research in health care decision in their own country/regio

On 13 Oct, 2021, our outstanding presenters received big achievements by winning amazing awards at the 9th HTAsiaLink Annual Virtual Conference 2021 which virtually held on 11 – 13  October 2021. The winners are as listed below:Best Oral Presentation HSS 1st WINNER: Chanida EkakkararungrojBest Poste

The more controversial of two papers describing how the lethal H5N1 bird flu could be made easier to spread was published Thursday, six months after a scientific advisory board suggested that the papers’ most potentially dangerous data be censored.The paper, by scientists at Erasmus Medical Center i

WASHINGTON — It would seem a business executive’s dream: legally pay a competitor to keep its product off the market for years.Congress has failed to stop it, and for more than a decade generic drug makers and big-name pharmaceutical companies have been winning court rulings that allowed it.Until th